{"content":"<li class=\"n-box-item date-title\" data-end=\"1575694799\" data-start=\"1575608400\" data-txt=\"Monday, December 23, 2019\">Friday, December  6, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3524611\" data-ts=\"1575672572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524611-eric-blue-and-tcom-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ERIC, BLUE and TCOM among notable after hours movers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva SA'>OBSV</a> <font color=\"green\">+20.4%</font>. <a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color=\"green\">+4.8%</font>. <a href='https://seekingalpha.com/symbol/KLXE' title='KLX Energy Services Holdings, Inc.'>KLXE</a> <font color=\"green\">+3.4%</font>. <a href='https://seekingalpha.com/symbol/FLEX' title='Flex Ltd.'>FLEX</a> <font color=\"green\">+2.6%</font>.</li><li><b>Losers: </b><a href='https://seekingalpha.com/symbol/DDOG' title='Datadog, Inc.'>DDOG</a> <font color=\"red\">-3%</font>. <a href='https://seekingalpha.com/symbol/INSW' title='International Seaways, Inc.'>INSW</a> <font color=\"red\">-2.6%</font>. <a href='https://seekingalpha.com/symbol/TCOM' title='Trip.com Group Limited'>TCOM</a> <font color=\"red\">-1.5%</font>. <a href='https://seekingalpha.com/symbol/ERIC' title='Telefonaktiebolaget LM Ericsson &#40;publ&#41;'>ERIC</a> <font color=\"red\">-1.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524611\" data-linked=\"ERIC, BLUE and TCOM among notable after hours movers\" data-tweet=\"$OBSV $BLUE $KLXE - ERIC, BLUE and TCOM among notable after hours movers https://seekingalpha.com/news/3524611-eric-blue-and-tcom-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524611-eric-blue-and-tcom-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524580\" data-ts=\"1575669994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524580-uso-oil-uwt-and-dwt-among-weekly-etf-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USO, OIL, UWT and DWT among weekly ETF movers</a></h4><ul><li><strong>Gainers: </strong>Velocity 3X Long Crude Oil (NYSEARCA:<a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>) <font color=\"green\">+18.7%</font>.</li><li>United States 3X Oil Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/USOU' title='USCF Funds Trust - United States 3x Oil Fund'>USOU</a>) <font color=\"green\">+18.5%</font>.</li><li>Ultrapro Crude Oil Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/OILU' title='ProShares Trust II - ProShares UltraPro 3x Crude Oil ETF'>OILU</a>) <font color=\"green\">+18.4%</font>.</li><li>UBS Etracs 3X Long Crude ETN (NYSEARCA:<a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>) <font color=\"green\">+18.4%</font>.</li><li>Direxion Brazil Bull 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/BRZU' title='Direxion Daily Brazil Bull 3x Shares ETF'>BRZU</a>) <font color=\"green\">+16.8%</font>.</li><li><strong>Losers: </strong>UBS Etracs 3X Inverse Crude ETN (NYSEARCA:<a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>) <font color=\"red\">-17.8%</font>.</li><li>Ultrapro Short Crude Oil Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/OILD' title='ProShares Trust II - ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>) <font color=\"red\">-17.8%</font>.</li><li>United States 3X Short Oil Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/USOD' title='USCF Funds Trust - United States 3x Short Oil Fund'>USOD</a>) <font color=\"red\">-17.7%</font>.</li><li>Velocity 3X Inverse Crude Oil (NYSEARCA:<a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>) <font color=\"red\">-17.6%</font>.</li><li>Direxion S&amp;P Oil &amp; Gas Expl Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>) <font color=\"red\">-13.6%</font>.</li><li><strong>Top non-leveraged gainers: </strong>Chile Ishares MSCI ETF (BATS:<a href='https://seekingalpha.com/symbol/ECH' title='iShares MSCI Chile Capped ETF'>ECH</a>) <font color=\"green\">+8.7%</font>.</li><li>Ipath.B S&amp;P GSCI Crude Oil (NYSEARCA:<a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>) <font color=\"green\">+6.3%</font>.</li><li>Crude Oil Strategy Proshares (BATS:<a href='https://seekingalpha.com/symbol/OILK' title='ProShares Trust - ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>) <font color=\"green\">+6.2%</font>.</li><li>S&amp;P Oil &amp; Gas Eqpt &amp; Services SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>) <font color=\"green\">+6.1%</font>.</li><li>US Oil Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>) <font color=\"green\">+6.0%</font>.</li><li><strong>Top non-leveraged losers: </strong>Advisorshares Pure Cannabis ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/YOLO' title='AdvisorShares Pure Cannabis ETF'>YOLO</a>)<font color=\"red\"> -5.6%</font>.</li><li>Spinnaker ETF Series The Cannabis ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/THCX' title='Spinnaker ETF Series - The Cannabis ETF'>THCX</a>) <font color=\"red\">-4.6%</font>.</li><li>Cambria Cannabis ETF (BATS:<a href='https://seekingalpha.com/symbol/TOKE' title='Cambria ETF Trust - Cambria Cannabis ETF'>TOKE</a>)<font color=\"red\"> -3.9%</font>.</li><li>Global X Cannabis ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/POTX' title='Global X Funds - Global X Cannabis Etf'>POTX</a>)<font color=\"red\"> -3.5%</font>.</li><li>G-X FTSE Greece 20 ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/GREK' title='Global X MSCI Greece ETF'>GREK</a>) <font color=\"red\">-3.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524580\" data-linked=\"USO, OIL, UWT and DWT among weekly ETF movers\" data-tweet=\"$UWT $USOU $OILU - USO, OIL, UWT and DWT among weekly ETF movers https://seekingalpha.com/news/3524580-uso-oil-uwt-and-dwt-among-weekly-etf-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524580-uso-oil-uwt-and-dwt-among-weekly-etf-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524568\" data-ts=\"1575668820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524568-bristol-myers-and-bluebird-bios-car-t-successful-in-mid-stage-mm-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers and bluebird bio&#39;s CAR T successful in mid-stage MM study</a></h4><ul><li>Bluebird bio (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) and licensee Bristol-Myers Squibb (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) <a href=\"https://seekingalpha.com/pr/17721203-bristol-myers-squibb-and-bluebird-bio-announce-positive-top-line-results-from-pivotal-phase-2\" target=\"_blank\">announce </a>positive topline results from a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03361748?term=NCT03361748&amp;draw=2&amp;rank=1\" target=\"_blank\">KarMMa</a>, evaluating CAR T therapy idecabtagene vicleucel (ide-cel) (bb2121) in treatment-resistant multiple myeloma &#40;MM&#41; patients.</li><li>The study met the primary and key secondary endpoints. Specifically, the overall response rate &#40;ORR&#41; was 73.4% (n=94/128) across three doses (primary endpoint). The response rate was dose-dependent, 50.0% (n=2/4) in the lowest, 68.6% (n=48/70) in the middle and 81.5% (n=44/54) in the highest. The complete response rates were 25%, 28.6% and 35.2%, respectively.</li><li>Median duration of response was 10.6 months and median progression-free survival was 8.6 months.</li><li>The safety profile was consistent with the Phase 1 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02658929?intr=bb2121&amp;lead=celgene&amp;phase=0&amp;draw=2&amp;rank=1\" target=\"_blank\">CRB-401</a> trial. The rate of serious/life-threatening/fatal cytokine release syndrome &#40;CRS&#41; was 5.5% (n=7/128) including one death. CRS of any grade occurred in 83.6% of subjects (n=107/128). The rate of serious neurotoxicity events was 3.1% (n=4/128).</li><li>More detailed data will be submitted for presentation at a future medical conference.</li><li>BMY and BLUE are both up <font color=\"green\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524568\" data-linked=\"Bristol-Myers and bluebird bio&#39;s CAR T successful in mid-stage MM study\" data-tweet=\"$BLUE $BMY - Bristol-Myers and bluebird bio&#39;s CAR T successful in mid-stage MM study https://seekingalpha.com/news/3524568-bristol-myers-and-bluebird-bios-car-t-successful-in-mid-stage-mm-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3524568-bristol-myers-and-bluebird-bios-car-t-successful-in-mid-stage-mm-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524553\" data-ts=\"1575666417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDX\" target=\"_blank\">CLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524553-celldex-files-for-150m-mixed-shelf\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celldex files for $150M mixed shelf</a></h4><ul><li>Celldex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc.'>CLDX</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/744218/000104746919006714/a2240232zs-3.htm\" target=\"_blank\">prospectus </a>for a $150M mixed shelf offering.</li><li>Shares down <font color=\"red\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524553\" data-linked=\"Celldex files for $150M mixed shelf\" data-tweet=\"$CLDX - Celldex files for $150M mixed shelf https://seekingalpha.com/news/3524553-celldex-files-for-150m-mixed-shelf?source=tweet\" data-url=\"https://seekingalpha.com/news/3524553-celldex-files-for-150m-mixed-shelf\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524552\" data-ts=\"1575666318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLL\" target=\"_blank\">BLL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524552-ball-shares-battered-way-cleared-for-florida-aluminum-can-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ball shares battered as way cleared for Florida aluminum can plant</a></h4><ul><li>Ball Corp. (<a href='https://seekingalpha.com/symbol/BLL' title='Ball Corporation'>BLL</a> <font color='red'>-3.9%</font>) is today's biggest decliner on the S&amp;P 500, sliding to six-month lows in an apparent reaction to news that a privately-owned Florida company plans to invest in building a <a href=\"https://www.theledger.com/business/20191205/winter-haven-clears-way-for-can-manufacturing-plant---110-new-jobs\" target=\"_blank\">new aluminum can manufacturing plant</a> in the state.</li><li>The Winter Haven City Commission voted to clear the way for the $120M plant, which is scheduled to open in Q1 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524552\" data-linked=\"Ball shares battered as way cleared for Florida aluminum can plant\" data-tweet=\"$BLL - Ball shares battered as way cleared for Florida aluminum can plant https://seekingalpha.com/news/3524552-ball-shares-battered-way-cleared-for-florida-aluminum-can-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3524552-ball-shares-battered-way-cleared-for-florida-aluminum-can-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524551\" data-ts=\"1575666301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524551-t-mobile-sprint-in-talks-ny-ag-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile, Sprint in talks with NY AG - report</a></h4><ul><li>T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) <font color=\"green\">+1%</font> and Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) <font color=\"green\">+2.2%</font> close the day up after Fox Business News journalist Charles Gasparino <a href=\"https://twitter.com/CGasparino/status/1203045422169755648?s=20\" target=\"_blank\">tweets</a> that the companies are in last-minute settlement talks with New York's AG.</li><li>A court battle against a dozen state AGs who oppose the merger will begin on Monday. The companies <a href=\"https://seekingalpha.com/news/3521837-texas-ag-settles-t-mobile-sprint\" target=\"_blank\">recently settled</a> with Texas, which led to the state dropping out of the case.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524551\" data-linked=\"T-Mobile, Sprint in talks with NY AG - report\" data-tweet=\"$TMUS $S - T-Mobile, Sprint in talks with NY AG - report https://seekingalpha.com/news/3524551-t-mobile-sprint-in-talks-ny-ag-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3524551-t-mobile-sprint-in-talks-ny-ag-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524549\" data-ts=\"1575665772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524549-halliburton-lays-off-70-california-employees-in-latest-round-of-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halliburton lays off 70 California employees in latest round of cuts</a></h4><ul><li>Halliburton (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='green'>+4.1%</font>) is <a href=\"https://www.reuters.com/article/us-halliburton-layoffs/halliburton-lays-off-70-employees-at-bakersfield-plant-in-california-idUSKBN1YA28X\" target=\"_blank\">laying off ~70 employees</a> at its Bakersfield plant in California amid the slowdown in oil and gas drilling activity, according to a filing with state authorities.</li><li>The news follows HAL's announced <a href=\"https://seekingalpha.com/news/3523223-halliburton-to-cut-800-plus-jobs-in-oklahoma\" target=\"_blank\">plant closure in Oklahoma</a> that caused layoffs of more than 800 employee; in October, the company cut 650 jobs across Colorado, Wyoming, New Mexico and North Dakota.</li><li>Evidence of the industry's slump: More than 50 frac spreads have left the Permian  Basin this year, according to estimates from the Primary Vision consultancy firm.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524549\" data-linked=\"Halliburton lays off 70 California employees in latest round of cuts\" data-tweet=\"$HAL - Halliburton lays off 70 California employees in latest round of cuts https://seekingalpha.com/news/3524549-halliburton-lays-off-70-california-employees-in-latest-round-of-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3524549-halliburton-lays-off-70-california-employees-in-latest-round-of-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524544\" data-ts=\"1575664582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524544-petrobras-ceo-wants-fast-sale-of-braskem-improved-brazil-auction-process\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras CEO wants fast sale of Braskem, improved Brazil auction process</a></h4><ul><li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petróleo Brasileiro S.A. - Petrobras'>PBR</a> <font color='green'>+2.3%</font>) CEO Roberto Castello Branco says he <a href=\"https://www.reuters.com/article/us-brazil-energy-petrobras/petrobras-seeks-swift-sale-of-braskem-smoother-offshore-auction-process-idUSKBN1YA25Z\" target=\"_blank\">wants to sell</a> the company's stake in Brazilian petrochemical company Braskem (<a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+3.3%</font>) within a year.</li><li>Creditors of construction conglomerate Odebrecht, which also has a large stake in BAK, reportedly are in advanced talks to delay the sale of the crown jewel asset for another 2-3 years, but \"it's a very long period of time to sell a company,\" Castello Branco tells a meeting of investors in London.</li><li>The CEO also says the Brazilian government's process for offering offshore oil blocks must be refined, with the current bidding system allowing PBR a privileged position.</li><li>Last month, no major global oil companies committed to participate in an auction for the blocks in a major blow to Brazil's ambitions of developing the sector.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524544\" data-linked=\"Petrobras CEO wants fast sale of Braskem, improved Brazil auction process\" data-tweet=\"$PBR $BAK - Petrobras CEO wants fast sale of Braskem, improved Brazil auction process https://seekingalpha.com/news/3524544-petrobras-ceo-wants-fast-sale-of-braskem-improved-brazil-auction-process?source=tweet\" data-url=\"https://seekingalpha.com/news/3524544-petrobras-ceo-wants-fast-sale-of-braskem-improved-brazil-auction-process\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524537\" data-ts=\"1575662369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524537-domo-and-evolent-health-tech-gainers-globalscape-and-yext-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Domo and Evolent Health Tech gainers; GlobalSCAPE and Yext among losers</a></h4><ul><li><b>Gainers: </b>Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>) <font color=\"green\">+16%</font>. Evolent Health (NYSE:<a href='https://seekingalpha.com/symbol/EVH' title='Evolent Health, Inc.'>EVH</a>) <font color=\"green\">+13%</font>. Progyny (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNY' title='Progyny, Inc.'>PGNY</a>) <font color=\"green\">+11%</font>. Aurora Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/JG' title='Aurora Mobile Limited'>JG</a>) <font color=\"green\">+11%</font>. DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>GlobalSCAPE (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSB' title='GlobalSCAPE, Inc.'>GSB</a>) <font color=\"red\">-20%</font>. Yext (NYSE:<a href='https://seekingalpha.com/symbol/YEXT' title='Yext, Inc.'>YEXT</a>) <font color=\"red\">-14%</font>. PagerDuty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) <font color=\"red\">-12%</font>. Zoom Video Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>) <font color=\"red\">-10%</font>. IDT Corporation (NYSE:<a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524537\" data-linked=\"Domo and Evolent Health Tech gainers; GlobalSCAPE and Yext among losers\" data-tweet=\"$DOMO $EVH $PGNY - Domo and Evolent Health Tech gainers; GlobalSCAPE and Yext among losers https://seekingalpha.com/news/3524537-domo-and-evolent-health-tech-gainers-globalscape-and-yext-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524537-domo-and-evolent-health-tech-gainers-globalscape-and-yext-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524535\" data-ts=\"1575660865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524535-strike-ends-teck-resources-andacollo-mine-in-chile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strike ends at Teck Resources&#39; Andacollo mine in Chile</a></h4><ul><li>Teck Resources (<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color=\"green\">+1.7%</font>) says <a href=\"https://seekingalpha.com/pr/17720600-royal-gold-provides-update-from-teck-resources-on-resumption-of-operations-carmen-de\" target=\"_blank\">operations have resumed</a> at its Carmen de Andacollo mine in Chile after the Andacollo Workers Union ratified a new 36-month collective agreement, ending a strike that began in mid-October.</li><li>Royal Gold (<a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color=\"red\">-2.9%</font>) owns the right to purchase 100% of the payable gold produced from Andacollo until 900K oz. have been delivered and 50% of the payable gold thereafter.</li><li>Andacollo produced ~15K metric tons of copper during H1; Teck says the strike <a href=\"https://www.bnamericas.com/en/news/strike-at-teck-chilean-mine-ends\" target=\"_blank\">did not have a major impact</a> on 2019 output.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524535\" data-linked=\"Strike ends at Teck Resources&#39; Andacollo mine in Chile\" data-tweet=\"$TECK $RGLD - Strike ends at Teck Resources&#39; Andacollo mine in Chile https://seekingalpha.com/news/3524535-strike-ends-teck-resources-andacollo-mine-in-chile?source=tweet\" data-url=\"https://seekingalpha.com/news/3524535-strike-ends-teck-resources-andacollo-mine-in-chile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524533\" data-ts=\"1575660214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECA\" target=\"_blank\">ECA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524533-encana-cut-barclays-shares-rise-on-opec-production-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Encana cut at Barclays but shares rise on OPEC+ production deal</a></h4><ul><li>Encana (<a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a> <font color='green'>+2.9%</font>) is <a href=\"https://thefly.com/thestreet/realmoney/index.php/ECAid3003201/ECA-Encana-downgraded-to-Equal-Weight-from-Overweight-at-Barclays\" target=\"_blank\">downgraded</a> to Equal Weight from  Overweight with a $5 price target, slashed from $11, at Barclays, citing the company's leverage and \"below average\" total return yield.</li><li>While ECA has enjoyed positive operational momentum in the STACK with lower costs and six-month oil production exceeding its type curve, the play is a \"show-me\" story that will take time to prove out, Barclays analyst Janine Wai says.</li><li>ECA and other oil and gas names are broadly higher today following OPEC's agreement on additional production cuts.</li><li>ECA's average <a href=\"https://seekingalpha.com/symbol/ECA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> and <a href=\"https://seekingalpha.com/symbol/ECA/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> are Bullish, while its <a href=\"https://seekingalpha.com/symbol/ECA/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524533\" data-linked=\"Encana cut at Barclays but shares rise on OPEC+ production deal\" data-tweet=\"$ECA - Encana cut at Barclays but shares rise on OPEC+ production deal https://seekingalpha.com/news/3524533-encana-cut-barclays-shares-rise-on-opec-production-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3524533-encana-cut-barclays-shares-rise-on-opec-production-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524532\" data-ts=\"1575659469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524532-klx-energy-services-and-sundance-energy-among-energy-materials-gainers-first-majestic-silver\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KLX Energy Services and Sundance Energy among Energy/Materials gainers; First Majestic Silver and Coeur Mining losers</a></h4><ul><li><b>Gainers: </b>KLX Energy Services (NASDAQ:<a href='https://seekingalpha.com/symbol/KLXE' title='KLX Energy Services Holdings, Inc.'>KLXE</a>) <font color=\"green\">+30%</font>. Sundance Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy, Inc.'>SNDE</a>) <font color=\"green\">+23%</font>. Covia (NYSE:<a href='https://seekingalpha.com/symbol/CVIA' title='Covia Holdings Corporation'>CVIA</a>) <font color=\"green\">+20%</font>. Forum Energy Technologies (NYSE:<a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies, Inc.'>FET</a>) <font color=\"green\">+13%</font>. Chemours (NYSE:<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a>) <font color=\"green\">+12%</font>.</li><li><b>Losers: </b>First Majestic Silver (NYSE:<a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a>) <font color=\"red\">-6%</font>. Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>) <font color=\"red\">-6%</font>. Fortuna Silver Mines (NYSE:<a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines Inc.'>FSM</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524532\" data-linked=\"KLX Energy Services and Sundance Energy among Energy/Materials gainers; First Majestic Silver and Coeur Mining losers\" data-tweet=\"$KLXE $SNDE $CVIA - KLX Energy Services and Sundance Energy among Energy/Materials gainers; First Majestic Silver and Coeur Mining losers https://seekingalpha.com/news/3524532-klx-energy-services-and-sundance-energy-among-energy-materials-gainers-first-majestic-silver?source=tweet\" data-url=\"https://seekingalpha.com/news/3524532-klx-energy-services-and-sundance-energy-among-energy-materials-gainers-first-majestic-silver\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524525\" data-ts=\"1575655584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524525-hovnanian-enterprises-leads-industrial-gainers-losers-none\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hovnanian Enterprises leads industrial gainers; losers none</a></h4><ul><li><b>Gainers: </b>Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"green\">+8%</font>. IES Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/IESC' title='IES Holdings, Inc.'>IESC</a>) <font color=\"green\">+8%</font>. Gates Industrial (NYSE:<a href='https://seekingalpha.com/symbol/GTES' title='Gates Industrial Corporation plc'>GTES</a>) <font color=\"green\">+7%</font>. Titan International (NYSE:<a href='https://seekingalpha.com/symbol/TWI' title='Titan International, Inc.'>TWI</a>) <font color=\"green\">+6%</font>. BioHiTech Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BHTG' title='BioHiTech Global, Inc.'>BHTG</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>None</li></ul><div class=\"tiny-share-widget\" data-id=\"3524525\" data-linked=\"Hovnanian Enterprises leads industrial gainers; losers none\" data-tweet=\"$HOV $IESC $GTES - Hovnanian Enterprises leads industrial gainers; losers none https://seekingalpha.com/news/3524525-hovnanian-enterprises-leads-industrial-gainers-losers-none?source=tweet\" data-url=\"https://seekingalpha.com/news/3524525-hovnanian-enterprises-leads-industrial-gainers-losers-none\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524524\" data-ts=\"1575655523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524524-pier-1-imports-gains-after-report-of-guggenheim-engagement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier 1 Imports gains after report of Guggenheim engagement</a></h4><ul> <li>Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports, Inc.'>PIR</a>) is <font color=\"green\">up 1.70%</font> after Debtwire <a href=\"https://twitter.com/Debtwire/status/1202996777932210176?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet\" target=\"_blank\">reports</a> that the retailer has hired Guggenheim as a financial advisor.</li> <li>Previously, Pier 1 Imports brought on AlixPartners for operational assistance and Credit Suisse to help it explore strategic alternatives.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3524524\" data-linked=\"Pier 1 Imports gains after report of Guggenheim engagement\" data-tweet=\"$PIR - Pier 1 Imports gains after report of Guggenheim engagement https://seekingalpha.com/news/3524524-pier-1-imports-gains-after-report-of-guggenheim-engagement?source=tweet\" data-url=\"https://seekingalpha.com/news/3524524-pier-1-imports-gains-after-report-of-guggenheim-engagement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524521\" data-ts=\"1575654909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524521-wellesley-bancorp-leads-financial-gainers-weidai-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wellesley Bancorp leads financial gainers; Weidai the only loser</a></h4><ul><li><b>Gainers:</b> Wellesley Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/WEBK' title='Wellesley Bancorp, Inc.'>WEBK</a>) <font color=\"green\">+31%</font>. EZCORP (NASDAQ:<a href='https://seekingalpha.com/symbol/EZPW' title='EZCORP, Inc.'>EZPW</a>) <font color=\"green\">+20%</font>. BRP Group (NASDAQ:<a href='https://seekingalpha.com/symbol/BRP' title='BRP Group, Inc.'>BRP</a>) <font color=\"green\">+11%</font>. Realogy Holdings (NYSE:<a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a>) <font color=\"green\">+7%</font>. Banco BBVA Argentina (NYSE:<a href='https://seekingalpha.com/symbol/BBAR' title='Banco BBVA Argentina S.A.'>BBAR</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:</b> Weidai (NYSE:<a href='https://seekingalpha.com/symbol/WEI' title='Weidai Ltd.'>WEI</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524521\" data-linked=\"Wellesley Bancorp leads financial gainers; Weidai the only loser\" data-tweet=\"$WEBK $EZPW $BRP - Wellesley Bancorp leads financial gainers; Weidai the only loser https://seekingalpha.com/news/3524521-wellesley-bancorp-leads-financial-gainers-weidai-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3524521-wellesley-bancorp-leads-financial-gainers-weidai-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524519\" data-ts=\"1575654401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524519-trnx-yext-big-and-cgix-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TRNX, YEXT, BIG and CGIX among midday movers</a></h4><ul><li><strong>Gainers: </strong>Genesco (NYSE:<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a>) <font color=\"green\">+33%</font>.</li><li>Wellesley Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/WEBK' title='Wellesley Bancorp, Inc.'>WEBK</a>) <font color=\"green\">+31%</font>.</li><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) <font color=\"green\">+29%</font>.</li><li>KLX Energy Services (NASDAQ:<a href='https://seekingalpha.com/symbol/KLXE' title='KLX Energy Services Holdings, Inc.'>KLXE</a>) <font color=\"green\">+25%</font>.</li><li>Sundance Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy, Inc.'>SNDE</a>) <font color=\"green\">+23%</font>.</li><li>Cancer Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a>) <font color=\"green\">+22%</font>.</li><li>DermTech (NASDAQ:<a href='https://seekingalpha.com/symbol/DMTK' title='DermTech, Inc.'>DMTK</a>) <font color=\"green\">+20%</font>.</li><li>Cassava Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVA' title='Cassava Sciences, Inc.'>SAVA</a>) <font color=\"green\">+19%</font>.</li><li>EZCORP (NASDAQ:<a href='https://seekingalpha.com/symbol/EZPW' title='EZCORP, Inc.'>EZPW</a>) <font color=\"green\">+19%</font>.</li><li>My Size (NASDAQ:<a href='https://seekingalpha.com/symbol/MYSZ' title='My Size, Inc.'>MYSZ</a>) <font color=\"green\">+14%</font>.</li><li><strong>Losers: </strong>Correvio Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CORV' title='Correvio Pharma Corp.'>CORV</a>) <font color=\"red\">-33%</font>.</li><li>Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>) <font color=\"red\">-24%</font>.</li><li>RTW Retailwinds (NYSE:<a href='https://seekingalpha.com/symbol/RTW' title='RTW Retailwinds, Inc.'>RTW</a>) <font color=\"red\">-24%</font>.</li><li>Axcella Health (NASDAQ:<a href='https://seekingalpha.com/symbol/AXLA' title='Axcella Health Inc.'>AXLA</a>) <font color=\"red\">-22%</font>.</li><li>Capricor Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a>) <font color=\"red\">-18%</font>.</li><li>Oyster Point Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/OYST' title='Oyster Point Pharma, Inc.'>OYST</a>) <font color=\"red\">-16%</font>.</li><li>Yext (NYSE:<a href='https://seekingalpha.com/symbol/YEXT' title='Yext, Inc.'>YEXT</a>) <font color=\"red\">-16%</font>.</li><li>Cabaletta Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/CABA' title='Cabaletta Bio, Inc.'>CABA</a>) <font color=\"red\">-16%</font>.</li><li>Hermitage Offshore Services (NYSE:<a href='https://seekingalpha.com/symbol/PSV' title='Hermitage Offshore Services Ltd.'>PSV</a>) <font color=\"red\">-13%</font>.</li><li>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524519\" data-linked=\"TRNX, YEXT, BIG and CGIX among midday movers\" data-tweet=\"$GCO $WEBK $BIG - TRNX, YEXT, BIG and CGIX among midday movers https://seekingalpha.com/news/3524519-trnx-yext-big-and-cgix-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524519-trnx-yext-big-and-cgix-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524513\" data-ts=\"1575652541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524513-no-ad-com-review-for-bristol-myers-luspatercept-for-mds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No Ad Com review for Bristol-Myers&#39; luspatercept for MDS</a></h4><ul><li>Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"green\">+2.2%</font>) and collaboration partner Acceleron Pharma (<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a> <font color=\"red\">-1.3%</font>) <a href=\"https://seekingalpha.com/pr/17721059-bristol-myers-squibb-and-acceleron-pharma-provide-update-on-fda-advisory-committee-for\" target=\"_blank\">announce</a> that, following a meeting with the FDA two days ago, there will be no advisory committee review of Celgene's marketing application seeking approval of Reblozyl (luspatercept-aamt) for the treatment of adult patients with very low-to-intermediate-risk myelodysplastic syndromes-associated anemia who have ring sideroblasts and require red blood cell transfusions. The review was scheduled for Wednesday, December 18.</li><li>The agency's April 4, 2020 action date remains as is.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524513\" data-linked=\"No Ad Com review for Bristol-Myers&#39; luspatercept for MDS\" data-tweet=\"$BMY $XLRN - No Ad Com review for Bristol-Myers&#39; luspatercept for MDS https://seekingalpha.com/news/3524513-no-ad-com-review-for-bristol-myers-luspatercept-for-mds?source=tweet\" data-url=\"https://seekingalpha.com/news/3524513-no-ad-com-review-for-bristol-myers-luspatercept-for-mds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524511\" data-ts=\"1575652409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IESC\" target=\"_blank\">IESC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524511-ies-holdingsplus-8-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IES Holdings +8% post Q4 results</a></h4><ul><li>IES Holdings (<a href='https://seekingalpha.com/symbol/IESC' title='IES Holdings, Inc.'>IESC</a> <font color=\"green\">+8.6%</font>) reported Q4 revenue growth of 22.5% Y/Y to $293.6M, and Adj. net income of $12.5M (+26% Y/Y).</li><li>Revenue by segments: Commercial &amp; Industrial $77.7M (+0.13% Y/Y); Communications $91M (+50.2% Y/Y); Infrastructure Solutions $36.8M (+37.3% Y/Y); and Residential $88.1M (+16.8% Y/Y).</li><li>Q4 Gross margin <font color=\"green\">improved by 50 bps</font> to 17.3%, and operating margin<font color=\"green\"> improved by 111 bps</font> to 4.7%.</li><li>Adj. EBITDA was $17M (+31.8% Y/Y), and margin <font color=\"green\">improved by 42 bps</font> to 5.8%.</li><li>Net cash provided by operating activities YTD was $38.7M, compared to $12.2M a year ago.</li><li>Company\u2019s backlog was ~$537M as of September 30, 2019.</li><li>During the quarter, the company repurchased 68,872 shares at an average price of $18.80 per share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524401-integrated-electrical-services-reports-q4-results\" target=\"_blank\">Integrated Electrical Services reports Q4 results</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3524511\" data-linked=\"IES Holdings +8% post Q4 results\" data-tweet=\"$IESC - IES Holdings +8% post Q4 results https://seekingalpha.com/news/3524511-ies-holdingsplus-8-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3524511-ies-holdingsplus-8-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524510\" data-ts=\"1575651885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CC\" target=\"_blank\">CC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524510-pfas-chemical-makers-climb-congress-makes-no-decision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PFAS chemical makers climb as Congress makes no decision</a></h4><ul><li>\"Forever chemical\" makers are bouncing off yesterday's slump after the <a href=\"https://news.bloombergenvironment.com/environment-and-energy/pallone-holds-fast-on-strict-pfas-provisions-in-defense-bill\" target=\"_blank\">U.S. House reached no final decision</a> on the PFAS designation as a \"hazardous chemical.\"</li><li>Chemours (<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a> <font color=\"green\">+13.3%</font>) jumps as much as 17% after dropping yesterday; <a href='https://seekingalpha.com/symbol/MMM' title='3M Company'>MMM</a> <font color=\"green\">+3.8%</font>, <a href='https://seekingalpha.com/symbol/DD' title='DuPont de Nemours, Inc.'>DD</a> <font color=\"green\">+2.8%</font>, <a href='https://seekingalpha.com/symbol/CTVA' title='Corteva, Inc.'>CTVA</a> <font color=\"green\">+1.9%</font>.</li><li>House Energy and Commerce Committee Chairman Pallone reportedly agreed to  drop the language for provisions to tighten the regulation of \"forever  chemicals\" through the FY 2020 defense authorization bill.</li><li>Height Capital analyst Josh Price says Senate  and House leadership could still push for stronger PFAS provisions before the  deal is finalized, but the news should temporarily improve sentiment around PFAS manufacturers.</li><li>Susquehanna's Tom Claps says even in the event of a future \"hazardous\" designation by Congress or the EPA, the near-term risk to CC, CTVA, DD and MMM in terms of remediation costs should still be low.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524510\" data-linked=\"PFAS chemical makers climb as Congress makes no decision\" data-tweet=\"$CC $MMM $DD - PFAS chemical makers climb as Congress makes no decision https://seekingalpha.com/news/3524510-pfas-chemical-makers-climb-congress-makes-no-decision?source=tweet\" data-url=\"https://seekingalpha.com/news/3524510-pfas-chemical-makers-climb-congress-makes-no-decision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524509\" data-ts=\"1575651555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524509-eastman-kodak-among-consumer-gainers-china-automotive-systems-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eastman Kodak among consumer gainers; China Automotive Systems only loser</a></h4><ul><li><b>Gainers: </b>Johnson Outdoors (NASDAQ:<a href='https://seekingalpha.com/symbol/JOUT' title='Johnson Outdoors Inc.'>JOUT</a>) <font color=\"green\">+12%</font>. National Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a>) <font color=\"green\">+10%</font>. Centric Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRC' title='Centric Brands Inc.'>CTRC</a>) <font color=\"green\">+8%</font>. Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Company'>KODK</a>) <font color=\"green\">+7%</font>. Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524509\" data-linked=\"Eastman Kodak among consumer gainers; China Automotive Systems only loser\" data-tweet=\"$JOUT $FIZZ $CTRC - Eastman Kodak among consumer gainers; China Automotive Systems only loser https://seekingalpha.com/news/3524509-eastman-kodak-among-consumer-gainers-china-automotive-systems-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3524509-eastman-kodak-among-consumer-gainers-china-automotive-systems-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524507\" data-ts=\"1575651340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIG\" target=\"_blank\">BIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524507-shorts-fried-big-lots-jumps-26-post-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shorts fried as Big Lots jumps 26% post-results</a></h4><ul><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) posted a Q3 loss, <a href=\"https://seekingalpha.com/news/3524315-big-lots-eps-beats-0_02-beats-on-revenue\" target=\"_blank\">but topped estimates</a>, and CEO Bruce Thorn says a return to EBIT and EPS growth is in the cards for 2020, and set to accelerate further in 2021 and 2022.</li><li>As for this year's holiday season, sales are \"ahead of plan.\"</li><li><font color=\"red\">Down more than 50%</font> since late April, shares are <font color=\"green\">ahead 26% </font>in today's session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524507\" data-linked=\"Shorts fried as Big Lots jumps 26% post-results\" data-tweet=\"$BIG - Shorts fried as Big Lots jumps 26% post-results https://seekingalpha.com/news/3524507-shorts-fried-big-lots-jumps-26-post-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3524507-shorts-fried-big-lots-jumps-26-post-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524496\" data-ts=\"1575650193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGB\" target=\"_blank\">TGB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524496-taseko-first-nations-group-agree-to-new-prosperity-litigation-standstill\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taseko, First Nations group agree to New Prosperity litigation standstill</a></h4><ul><li>Taseko Mines (<a href='https://seekingalpha.com/symbol/TGB' title='Taseko Mines Limited'>TGB</a> <font color='green'>+2.4%</font>) moves higher after saying it <a href=\"https://www.miningweekly.com/article/taseko-and-tilhqotin-agree-to-litigation-standstill-over-new-prosperity-2019-12-06\" target=\"_blank\">reached agreement</a> with the Tŝilhqot'in Nation to a standstill on some outstanding litigation and regulatory matters related to the conflict over the proposed New Prosperity copper and gold mine in British Columbia.</li><li>Tŝilhqot'in is opposed to the development of the open pit mine near Teztan Biny (Fish Lake), which it considers a sacred lake.</li><li>New Prosperity is the largest undeveloped copper/gold deposit in  Canada, with a 1B-ton measured and  indicated resource containing 5.3B lbs. of copper and  13.3M oz. of gold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524496\" data-linked=\"Taseko, First Nations group agree to New Prosperity litigation standstill\" data-tweet=\"$TGB - Taseko, First Nations group agree to New Prosperity litigation standstill https://seekingalpha.com/news/3524496-taseko-first-nations-group-agree-to-new-prosperity-litigation-standstill?source=tweet\" data-url=\"https://seekingalpha.com/news/3524496-taseko-first-nations-group-agree-to-new-prosperity-litigation-standstill\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524480\" data-ts=\"1575649073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDX\" target=\"_blank\">GDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524480-metals-mining-stocks-mired-in-red-after-strong-u-s-jobs-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Metals, mining stocks mired in the red after strong U.S. jobs data</a></h4><ul><li>Precious metals miners (<a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a> <font color=\"red\">-1.7%</font>) are shunned in today's broad-based stock market rally, as stronger than expected <a href=\"https://seekingalpha.com/news/3524399-november-payrolls-blowout-266k-jobs-added-ue-rate-to-3_5\" target=\"_blank\">U.S. jobs data</a> alleviates economic concerns that had sparked safe-haven demand for gold and silver.</li><li>February Comex gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) <font color=\"red\">-1.2% </font>to $1,465.70/oz., wiping out a weekly gain, and January silver <font color=\"red\">-2.3%</font> to $16.57/oz.</li><li>The jobs report is \"a blow-away number: It means there will be no more  interest-rate cut, which is <a href=\"https://www.bnnbloomberg.ca/gold-futures-drop-as-u-s-payrolls-rise-more-than-expected-1.1358678\" target=\"_blank\">bearish for gold</a>,\" says Phil Streible,  senior market strategist at RJO Futures.</li><li>Among gold and silver names: <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color=\"red\">-1%</font>, <a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp.'>WPM</a> <font color=\"red\">-1.7%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color=\"red\">-1.8%</font>, <a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color=\"red\">-2%</font>, <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a> <font color=\"red\">-2.2%</font>, <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color=\"red\">-2.6%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color=\"red\">-2.7%</font>, <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color=\"red\">-2.8%</font>, <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines Inc.'>FSM</a> <font color=\"red\">-3.4%</font>, <a href='https://seekingalpha.com/symbol/PAAS' title='Pan American Silver Corp.'>PAAS</a> <font color=\"red\">-3.6%</font>, <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color=\"red\">-4.1%</font>, <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color=\"red\">-5.1%</font>, <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color=\"red\">-5.3%</font>, <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Company'>HL</a> <font color=\"red\">-6.8%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/XME' title='SPDR S&P Metals and Mining ETF'>XME</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares, Inc. - iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/GOAU' title='U.S. Global GO GOLD and Precious Metal Miners ETF'>GOAU</a>, <a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott ETF Trust - Sprott Junior Gold Miners ETF'>SGDJ</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Trust - ProShares Ultra Gold Miners'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3524480\" data-linked=\"Metals, mining stocks mired in the red after strong U.S. jobs data\" data-tweet=\"$GDX $GLD $GOLD - Metals, mining stocks mired in the red after strong U.S. jobs data https://seekingalpha.com/news/3524480-metals-mining-stocks-mired-in-red-after-strong-u-s-jobs-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3524480-metals-mining-stocks-mired-in-red-after-strong-u-s-jobs-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524482\" data-ts=\"1575648407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524482-clovis-oncology-among-healthcare-gainers-curis-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clovis Oncology among healthcare gainers; Curis among losers</a></h4><ul><li><b>Gainers: </b>Cassava Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVA' title='Cassava Sciences, Inc.'>SAVA</a>) <font color=\"green\">+23%</font>. Cancer Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a>) <font color=\"green\">+23%</font>. Epizyme (NASDAQ:<a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme, Inc.'>EPZM</a>) <font color=\"green\">+15%</font>. Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"green\">+15%</font>. Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology, Inc.'>CLVS</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>Correvio Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CORV' title='Correvio Pharma Corp.'>CORV</a>) <font color=\"red\">-33%</font>. Capricor Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a>) <font color=\"red\">-17%</font>. Curis (NASDAQ:<a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a>) <font color=\"red\">-16%</font>. Axcella Health (NASDAQ:<a href='https://seekingalpha.com/symbol/AXLA' title='Axcella Health Inc.'>AXLA</a>) <font color=\"red\">-16%</font>. IMAC (NASDAQ:<a href='https://seekingalpha.com/symbol/IMAC' title='IMAC Holdings, Inc.'>IMAC</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524482\" data-linked=\"Clovis Oncology among healthcare gainers; Curis among losers\" data-tweet=\"$SAVA $CGIX $EPZM - Clovis Oncology among healthcare gainers; Curis among losers https://seekingalpha.com/news/3524482-clovis-oncology-among-healthcare-gainers-curis-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524482-clovis-oncology-among-healthcare-gainers-curis-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524484\" data-ts=\"1575648339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMM\" target=\"_blank\">MMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524484-3m-planning-1b-sale-of-drug-delivery-systems-unit-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3M planning $1B sale of drug delivery systems unit - Bloomberg</a></h4><ul><li>3M (<a href='https://seekingalpha.com/symbol/MMM' title='3M Company'>MMM</a> <font color='green'>+3.8%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2019-12-06/3m-is-said-to-plan-1-billion-sale-of-drug-delivery-systems-unit\" target=\"_blank\">exploring a sale</a> of its drug delivery systems unit in a deal that could fetch ~$1B, and is working with an adviser to run an auction process for the business, Bloomberg reports.</li><li>The drug delivery systems business, which makes products including asthma inhalers and skin  patches, likely will draw interest from P-E firms, according to the report.</li><li>3M dropped 1.7% yesterday after CFO Michael Roman  told the Credit Suisse Industrials conference that the company's Q4 \"looks a lot like Q3,\" and said \"there's still a lot of uncertainty out  there\" following recent trips to China and Europe.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524484\" data-linked=\"3M planning $1B sale of drug delivery systems unit - Bloomberg\" data-tweet=\"$MMM - 3M planning $1B sale of drug delivery systems unit - Bloomberg https://seekingalpha.com/news/3524484-3m-planning-1b-sale-of-drug-delivery-systems-unit-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3524484-3m-planning-1b-sale-of-drug-delivery-systems-unit-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524474\" data-ts=\"1575647832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524474-mcdonalds-comes-in-strong-new-chicken-sandwich\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDonald&#39;s comes in strong with new chicken sandwich</a></h4><ul> <li>Telsey Advisory Group says the new crispy chicken sandwich product from McDonald's (<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a> <font color=\"green\">+0.7%</font>) is almost <a href=\"https://www.cnbc.com/2019/12/06/telsey-advisory-mcdonalds-new-chicken-sandwich-is-really-good.html\" target=\"_blank\">ready</a> for primetime and should do well in a direct challenge to Chick-fil-A.</li> <li>\"We believe MCD's new Crispy Chicken Sandwich and Biscuit will usher in a successful new U.S. lineup of better-quality chicken in 2020 and 2021,\" says Telsey analyst Bob Derrington.</li> <li>After a test of the new sandwich by the research firm, the new crispy chicken breasts (lightly battered, juicier and more flavorful) are said to be a \"terrific upgrade\" from MCD's current crispy chicken sandwich. A national launch of the new crispy chicken sandwich could be a significant traffic driver for the chain if reviews keep coming in positive.</li> <li>McDonald's is also looking to win on price, with its new offering listing at $3.49 vs. $3.79 for Chick-fil-A comparable sandwich and $3.99 for Popeye's (NYSE:<a href='https://seekingalpha.com/symbol/QSR' title='Restaurant Brands International Inc.'>QSR</a>) sandwich.</li> <li>Keep an eye on Wingstop (NASDAQ:<a href='https://seekingalpha.com/symbol/WING' title='Wingstop Inc.'>WING</a>), which has peeled off about 18% over the last 90 days as the chicken sandwich war has heated up.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3524474\" data-linked=\"McDonald&#39;s comes in strong with new chicken sandwich\" data-tweet=\"$MCD $QSR $WING - McDonald&#39;s comes in strong with new chicken sandwich https://seekingalpha.com/news/3524474-mcdonalds-comes-in-strong-new-chicken-sandwich?source=tweet\" data-url=\"https://seekingalpha.com/news/3524474-mcdonalds-comes-in-strong-new-chicken-sandwich\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524469\" data-ts=\"1575647277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GS\" target=\"_blank\">GS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524469-goldman-boosted-1mdb-settlement-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman boosted by 1MDB settlement chatter</a></h4><ul><li>A headline on Bloomberg says a settlement of less than $2B is under discussion in the probe of Goldman's (NYSE:<a href='https://seekingalpha.com/symbol/GS' title='The Goldman Sachs Group, Inc.'>GS</a>) 1MDB involvement.</li><li>Shares have <font color=\"green\">popped just shy of 3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524469\" data-linked=\"Goldman boosted by 1MDB settlement chatter\" data-tweet=\"$GS - Goldman boosted by 1MDB settlement chatter https://seekingalpha.com/news/3524469-goldman-boosted-1mdb-settlement-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3524469-goldman-boosted-1mdb-settlement-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524464\" data-ts=\"1575646608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAC\" target=\"_blank\">PAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524464-grupo-aeroportuario-del-pacifico-reports-10_1-rise-in-november-traffic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grupo Aeroportuario Del Pacifico reports 10.1% rise in November traffic</a></h4><ul> <li>Grupo Aeroportuario del Pacifico (<a href='https://seekingalpha.com/symbol/PAC' title='Grupo Aeroportuario del Pacífico, S.A.B. de C.V.'>PAC</a> <font color='red'>-1.6%</font>) reports terminal traffic rose 10.1% in November at the company's 14 airports.</li><li>Domestic passenger traffic grew 7.5% and international traffic up 13.6%.</li><li>Number of seats available increased by 6.7% for the month.</li><li>The company's load factor improved 300 bps to 83.7%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524464\" data-linked=\"Grupo Aeroportuario Del Pacifico reports 10.1% rise in November traffic\" data-tweet=\"$PAC - Grupo Aeroportuario Del Pacifico reports 10.1% rise in November traffic https://seekingalpha.com/news/3524464-grupo-aeroportuario-del-pacifico-reports-10_1-rise-in-november-traffic?source=tweet\" data-url=\"https://seekingalpha.com/news/3524464-grupo-aeroportuario-del-pacifico-reports-10_1-rise-in-november-traffic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524458\" data-ts=\"1575645670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524458-korn-ferryminus-2_4-on-weak-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Korn Ferry -2.4% on weak margins</a></h4><ul><li>Korn Ferry (<a href='https://seekingalpha.com/symbol/KFY' title='Korn Ferry'>KFY</a> <font color=\"red\">-2.4%</font>) reports <a href=\"https://seekingalpha.com/pr/17720372-korn-ferry-announces-second-quarter-fiscal-2020-results-of-operations\" target=\"_blank\">Q2</a> total revenue of $504.2M (-0.5% Y/Y) &amp; 1% increase on a constant currency basis, the decrease in fee revenue was due to lower fee revenue.</li><li>Sales by segment: Executive Search: $192M (-5% Y/Y); Advisory: $213.9M (-3.6%); RPO &amp; Professional Search: $98.9M (+17.9%).</li><li>Operating margin by segment: Executive Search <font color=\"red\">declined 410 bps</font> to 21.9%; Advisory <font color=\"red\">declined 10 bps</font> to 13.5% &amp; RPO &amp; Professional Search <font color=\"green\">increased 30 bps</font> to 15.9%.</li><li>Adj. EBITDA margin by segment: Executive Search <font color=\"red\">declined 150 bps</font> to 23.4%; Advisory <font color=\"red\">declined 60 bps</font> to 17.6% &amp; RPO &amp; Professional Search <font color=\"green\">increased 60 bps</font> to 17%.</li><li>Total margins: Operating <font color=\"red\">declined 170 bps</font> to 12.6%; EBITDA <font color=\"red\">declined 30 bps</font> to 15.4% &amp; Adj. EBITDA also <font color=\"red\">decreased 30 bps</font> to 15.9%.</li><li>The Company continued with its balanced approach to capital allocation, buying back 1.3M of stock or $49.2M of stock during the quarter.</li><li>Also declared a quarterly dividend of $0.10/share payable on Jan. 15, 2020.</li><li><b>Q3 2020 Outlook</b>: Fee revenue expected to be ~$490-510M; GAAP EPS of ~$0.35-$0.52 and Non-GAAP EPS of $0.70-0.78.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524178-korn-ferry-declares-0_10-dividend\" target=\"_blank\">Korn/Ferry declares $0.10 dividend</a> (Dec. 05 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524172-korn-ferry-eps-in-line-beats-on-revenue\" target=\"_blank\">Korn/Ferry EPS in-line, beats on revenue</a> (Dec. 05 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3524458\" data-linked=\"Korn Ferry -2.4% on weak margins\" data-tweet=\"$KFY - Korn Ferry -2.4% on weak margins https://seekingalpha.com/news/3524458-korn-ferryminus-2_4-on-weak-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3524458-korn-ferryminus-2_4-on-weak-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524457\" data-ts=\"1575645576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524457-canada-reports-71k-job-loss-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada reports 71K job loss in November</a></h4><ul><li>Standing in sharp contrast to the big U.S. payroll numbers for November, <a href=\"https://www150.statcan.gc.ca/n1/daily-quotidien/191206/dq191206a-eng.htm?HPA=1\" target=\"_blank\">Canada lost 71.2K jobs</a> last month. Expectations were for a gain of 10K.</li><li>The unemployment rate shot higher to 5.9% from 5.5%.</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='Invesco CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) is <font color=\"red\">down 0.6%</font> vs. the greenback.</li><li>In other news up north, Bank of Canada Governor Stephen Poloz <a href=\"https://www.bankofcanada.ca/2019/12/bank-canada-governor-stephen-s-poloz-step-down-june-2020/\" target=\"_blank\">announces his exit </a>from that position as of June 2020.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/BBCA' title='JPMorgan BetaBuilders Canada ETF'>BBCA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Trust - iShares Currency Hedged MSCI Canada ETF'>HEWC</a>, <a href='https://seekingalpha.com/symbol/ZCAN' title='SPDR Index Shares Funds - SPDR Solactive Canada ETF'>ZCAN</a>, <a href='https://seekingalpha.com/symbol/FLCA' title='Franklin FTSE Canada ETF'>FLCA</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3524457\" data-linked=\"Canada reports 71K job loss in November\" data-tweet=\"$FXC $EWC $BBCA - Canada reports 71K job loss in November https://seekingalpha.com/news/3524457-canada-reports-71k-job-loss-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3524457-canada-reports-71k-job-loss-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524455\" data-ts=\"1575645096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CULP\" target=\"_blank\">CULP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524455-on-culps-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Culp&#39;s Q2 results</a></h4><ul><li>Culp (<a href='https://seekingalpha.com/symbol/CULP' title='Culp, Inc.'>CULP</a> <font color=\"green\">+1.3%</font>) reported Q2 revenue decline of 5.7% Y/Y to $72.6M, with mattress fabrics -4.7%, upholstery fabrics -3.2%, and home accessories -31.5%.</li><li>Q2 Gross margin <font color=\"green\">improved by 212 bps</font> to 19.4%; and operating margin <font color=\"red\">declined by 10 bps </font>to 5.5%.</li><li>SG&amp;A expenses were $10.12M (+0.2% Y/Y); and as percentage of revenue 13.9% up by 85 bps.</li><li>Cash flow from operations and free cash flow YTD were $8.2M and $5.6M.</li><li>Company currently expects performance in 4Q20 to be significantly better than the results achieved in 4Q19.</li><li>3Q20 Outlook: Overall sales to be comparable to the same period last year; Pre-tax income is expected to be in the range of $3.2M to $3.8M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524198-culp-declares-0_105-dividend\" target=\"_blank\">Culp declares $0.105 dividend</a> (Dec. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524196-culp-eps-beats-0_03-misses-on-revenue\" target=\"_blank\">Culp EPS beats by $0.03, misses on revenue</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3524455\" data-linked=\"More on Culp&#39;s Q2 results\" data-tweet=\"$CULP - More on Culp&#39;s Q2 results https://seekingalpha.com/news/3524455-on-culps-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3524455-on-culps-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524451\" data-ts=\"1575644659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEM\" target=\"_blank\">SEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524451-select-medical-prices-675m-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Medical prices $675M debt offering</a></h4><ul><li>Select Medical Holdings (<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color=\"green\">+2.6%</font>) has <a href=\"https://seekingalpha.com/pr/17720542-select-medical-corporation-announces-pricing-and-upsizing-of-offering-of-additional-675\" target=\"_blank\">priced </a>its private placement of $675M (up from $625M) of 6.250% senior notes due 2026 at par.</li><li>The company previously issued $550M of same notes.</li><li>Proceeds will help fund an intercompany loan to joint venture subsidiary Concentra which will use the money to repay outstanding loans and related fees and expenses.</li><li>Closing date is December 10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524451\" data-linked=\"Select Medical prices $675M debt offering\" data-tweet=\"$SEM - Select Medical prices $675M debt offering https://seekingalpha.com/news/3524451-select-medical-prices-675m-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3524451-select-medical-prices-675m-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524444\" data-ts=\"1575643825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASR\" target=\"_blank\">ASR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524444-asur-announces-traffic-update-for-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ASUR announces traffic update for November</a></h4><ul><li>Grupo Aeroportuario del Sureste (<a href='https://seekingalpha.com/symbol/ASR' title='Grupo Aeroportuario del Sureste, S. A. B. de C. V.'>ASR</a> <font color='green'>+0.4%</font>) <a href=\"https://seekingalpha.com/pr/17720451-asur-announces-total-passenger-traffic-for-november-2019\" sasource=\"qp_sum_news_1\" target=\"_blank\">reports</a> total passenger traffic rose 7.3% to 4.29M in November.</li><li>Passenger traffic expanded 3.9% in Mexico, 20.2% in Puerto Rico and 7.5% in Colombia.</li><li>Domestic traffic increased 9.1% and International traffic advanced 3.9%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524444\" data-linked=\"ASUR announces traffic update for November\" data-tweet=\"$ASR - ASUR announces traffic update for November https://seekingalpha.com/news/3524444-asur-announces-traffic-update-for-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3524444-asur-announces-traffic-update-for-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524429\" data-ts=\"1575641973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524429-alexion-confident-current-value-creating-path-no-sale-planned\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexion confident with current value-creating path, no sale planned</a></h4><ul><li>In a <a href=\"https://seekingalpha.com/pr/17720818-alexion-issues-statement-on-path-to-value-creation\" target=\"_blank\">statement</a>, Alexion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a>) says it has established a \"strong foundation\" to drive growth and boost shareholder value and does not plan to pursue an outright sale as proposed by shareholder Elliott Advisors.</li><li>Management cites it new leadership team, a refined strategy to convert the market to Ultomiris (ravulizumab-cwvz) from Soliris (eculizumab), the expansion of current assets into new diseases and a revamped pipeline.</li><li>Shares up <font color=\"green\">6%</font> premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524429\" data-linked=\"Alexion confident with current value-creating path, no sale planned\" data-tweet=\"$ALXN - Alexion confident with current value-creating path, no sale planned https://seekingalpha.com/news/3524429-alexion-confident-current-value-creating-path-no-sale-planned?source=tweet\" data-url=\"https://seekingalpha.com/news/3524429-alexion-confident-current-value-creating-path-no-sale-planned\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524427\" data-ts=\"1575641871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524427-citi-raises-docusign-ahead-of-fy21-strength\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi raises DocuSign ahead of FY21 strength</a></h4><ul><li>Citi raises DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) from $72 to $85 after the <a href=\"https://seekingalpha.com/news/3524180-docusignminus-4_3-despite-beats-upside-q4-view\" target=\"_blank\">earnings report </a>that \"sets up \u2018higher for longer\u2019 growth\" in FY21.</li><li>Analyst Walter Pritchard says the quarter was driven by an \"upside to subscription revenue.\" He sees DOCU's H2 performance supporting 30% subscription revenue growth in FY21.</li><li>DOCU shares are <font color=\"green\">up 8%</font> pre-market to $75.16. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/DOCU/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524427\" data-linked=\"Citi raises DocuSign ahead of FY21 strength\" data-tweet=\"$DOCU - Citi raises DocuSign ahead of FY21 strength https://seekingalpha.com/news/3524427-citi-raises-docusign-ahead-of-fy21-strength?source=tweet\" data-url=\"https://seekingalpha.com/news/3524427-citi-raises-docusign-ahead-of-fy21-strength\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524426\" data-ts=\"1575641760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIZZ\" target=\"_blank\">FIZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524426-national-beverage-shows-little-post-earnings-pop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Beverage shows a little post-earnings pop</a></h4><ul> <li>National Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a>) moves higher after the company <a href=\"https://seekingalpha.com/pr/17720512-national-beverage-corp-reports-solid-second-quarter-results-confident-enthusiasm\" target=\"_blank\">reports</a> November orders were ahead of last year's pace and the new Hi-Biscus line is being met with enthusiastic responses from both consumers and retailers.</li> <li>FIZZ's FQ2 revenue was down 3.49% Y/Y, but came in ahead of consensus expectations.</li> <li>Shares of FIZZ are <font color=\"green\">up 8.02%</font> to $52.11 on light premarket volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524243-national-beverage-eps-misses-0_02-beats-on-revenue\" target=\"_blank\">National Beverage EPS misses by $0.02, beats on revenue</a> (Dec. 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3524426\" data-linked=\"National Beverage shows a little post-earnings pop\" data-tweet=\"$FIZZ - National Beverage shows a little post-earnings pop https://seekingalpha.com/news/3524426-national-beverage-shows-little-post-earnings-pop?source=tweet\" data-url=\"https://seekingalpha.com/news/3524426-national-beverage-shows-little-post-earnings-pop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524423\" data-ts=\"1575641465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524423-yext-zm-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YEXT, ZM among premarket losers</a></h4><ul><li>Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>) <font color=\"red\">-30%</font>.</li><li>Correvio Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CORV' title='Correvio Pharma Corp.'>CORV</a>) <font color=\"red\">-25%</font>.</li><li>Yext (NYSE:<a href='https://seekingalpha.com/symbol/YEXT' title='Yext, Inc.'>YEXT</a>) <font color=\"red\">-24%</font> on <a href=\"https://seekingalpha.com/news/3524192-yext-eps-misses-0_01-revenue-in-line\" target=\"_blank\">Q3 earnings</a>.</li><li>PagerDuty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) <font color=\"red\">-17%</font> on <a href=\"https://seekingalpha.com/news/3524175-pagerduty-eps-misses-0_01-beats-on-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Zoom Video Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3524168-zoom-video-communications-eps-beats-0_06-beats-on-revenue\" target=\"_blank\">Q3 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3524423\" data-linked=\"YEXT, ZM among premarket losers\" data-tweet=\"$TRNX $CORV $YEXT - YEXT, ZM among premarket losers https://seekingalpha.com/news/3524423-yext-zm-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524423-yext-zm-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524419\" data-ts=\"1575641336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524419-ttd-ulta-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TTD, ULTA among premarket gainers</a></h4><ul><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) <font color=\"green\">+23%</font> after <a href=\"https://seekingalpha.com/news/3524315-big-lots-eps-beats-0_02-beats-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>) <font color=\"green\">+19%</font> after <a href=\"https://seekingalpha.com/news/3524170-domo-eps-beats-0_16-beats-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Cassava Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVA' title='Cassava Sciences, Inc.'>SAVA</a>) <font color=\"green\">+16%</font> on <a href=\"https://seekingalpha.com/news/3524329-cassava-up-41-premarket-on-encouraging-data-on-ptiminus-125-in-alzheimers\" target=\"_blank\">encouraging data</a> on PTI-125 in Alzheimer's.</li><li>Genesco (NYSE:<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a>) <font color=\"green\">+15%</font> after <a href=\"https://seekingalpha.com/news/3524333-genesco-eps-beats-0_25-misses-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Ulta Beauty (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a>) <font color=\"green\">+9%</font> after <a href=\"https://seekingalpha.com/news/3524161-ulta-beauty-eps-beats-0_10-misses-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) <font color=\"green\">+9%</font> after <a href=\"https://seekingalpha.com/news/3524167-docusign-eps-beats-0_07-beats-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) <font color=\"green\">+8%</font> after <a href=\"https://seekingalpha.com/news/3524174-cloudera-eps-beats-0_03-beats-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>J.Jill (NYSE:<a href='https://seekingalpha.com/symbol/JILL' title='J.Jill, Inc.'>JILL</a>) <font color=\"green\">+6%</font> after <a href=\"https://seekingalpha.com/news/3523922-j-jill-eps-misses-0_05-misses-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) <font color=\"green\">+6%</font> after <a href=\"https://seekingalpha.com/news/3524171-american-outdoor-brands-eps-beats-0_02-beats-on-revenue\" target=\"_blank\">Q2 results</a>.</li><li>The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) <font color=\"green\">+6%</font> <a href=\"https://seekingalpha.com/news/3524351-trade-deskplus-4-needham-leaves-sidelines\" target=\"_blank\">on positive analyst action</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524419\" data-linked=\"TTD, ULTA among premarket gainers\" data-tweet=\"$BIG $DOMO $SAVA - TTD, ULTA among premarket gainers https://seekingalpha.com/news/3524419-ttd-ulta-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524419-ttd-ulta-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524417\" data-ts=\"1575641297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PD\" target=\"_blank\">PD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524417-pagerduty-targets-cut-after-mixed-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PagerDuty targets cut after mixed quarter</a></h4><ul><li>RBC analyst Matthew Hedberg (Outperform) calls the <a href=\"https://seekingalpha.com/news/3524369-pagerduty-16_6-after-wider-loss-outlook\" target=\"_blank\">post-earnings </a>PagerDuty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) selloff \"overdone.\"</li><li>Hedberg says the results were in line to better and continues to find PD's \"thesis and valuation attractive.\"</li><li>RBC lowers its target from $43 to $30 on peer group compression.</li><li>More action: SunTrust maintains a Hold rating and cuts its target from $32 to $25, saying the results and execution in the quarter were mixed.</li><li>PD shares are <font color=\"red\">down 17.2%</font> pre-market to $20.70. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/PD/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524417\" data-linked=\"PagerDuty targets cut after mixed quarter\" data-tweet=\"$PD - PagerDuty targets cut after mixed quarter https://seekingalpha.com/news/3524417-pagerduty-targets-cut-after-mixed-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3524417-pagerduty-targets-cut-after-mixed-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524414\" data-ts=\"1575641048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524414-american-outdoor-brands-seeing-solid-handgun-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Outdoor Brands seeing solid handgun demand</a></h4><ul> <li>American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) CEO James Debney says the 2020 election has had no impact on consumer demand whatsoever to date. The exec notes that the company has the \"skill set\" to deploy quickly if there is some shift in demand due to the election.</li> <li>The company's revenue was down 4.52% Y/Y in Q3, but came in ahead of expectations. Management notes underlying handgun demand trends are improving, but demand for modern hunting rifles is still soft.</li> <li><a href=\"https://seekingalpha.com/article/4310962-american-outdoor-brands-corporation-aobc-ceo-james-debney-on-q2-2020-results-earnings-call\" target=\"_blank\">American Outdoor Brands earnings call transcript</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3524204-american-outdoor-brandsplus-8-after-strong-guidance\" target=\"_blank\">American Outdoor Brands +8% after strong guidance</a> (Dec. 5)</li> <li>Shares of AOBC are <font color=\"green\">up 5.99%</font> premarket to $10.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3524414\" data-linked=\"American Outdoor Brands seeing solid handgun demand\" data-tweet=\"$AOBC - American Outdoor Brands seeing solid handgun demand https://seekingalpha.com/news/3524414-american-outdoor-brands-seeing-solid-handgun-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3524414-american-outdoor-brands-seeing-solid-handgun-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524397\" data-ts=\"1575640711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRIS\" target=\"_blank\">CRIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524397-curis-up-8-premarket-on-encouraging-caminus-4948-in-nhl\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Curis up 8% premarket on encouraging CA-4948 in NHL</a></h4><ul><li>Thinly traded nano cap Curis (NASDAQ:<a href='https://seekingalpha.com/symbol/CRIS' title='Curis, Inc.'>CRIS</a>) perks up <font color=\"green\">8%</font> premarket on increased volume in reaction to <a href=\"https://seekingalpha.com/pr/17720735-curis-provides-first-ever-demonstration-targeting-irak4-in-patients-relapsed-refractory-non\" target=\"_blank\">updated preliminary data</a> from an ongoing <a href=\"https://clinicaltrials.gov/ct2/show/NCT03328078?lead=curis&amp;phase=0&amp;draw=2&amp;rank=1\" target=\"_blank\">Phase 1 clinical trial</a> evaluating CA-4948 in patients with relapsed/refractory non-Hodgkin lymphoma &#40;NHL&#41;, including some with diffuse large B-cell lymphoma &#40;DLBCL&#41;, Waldenström's macroglobulinemia &#40;WM&#41; and oncogenic MYD88 mutations.</li><li>83% (n=5/6) of evaluable subjects in the higher dose cohorts (200 mg twice daily and 400 mg twice daily) showed reduced tumor burden (29% average reduction). Three of the five are still on treatment after 33-51 weeks.</li><li>On the safety front, one participant in the 100 mg once-daily arm experienced dose-limiting toxicity (maculopapular rash) which resolved after steroid treatment. One patient in the 400 mg twice daily arm experienced serious <a href=\"https://www.webmd.com/a-to-z-guides/rhabdomyolysis-symptoms-causes-treatments#1\" target=\"_blank\">rhabdomyolysis</a> (a potentially life-threatening breakdown of muscle fibers resulting in the release of myoglobin into the bloodstream which can damage the kidneys).</li><li>CR-4948 inhibits an enzyme called interleukin-1 receptor-associated kinase 4 (<a href=\"https://en.wikipedia.org/wiki/IRAK4\" target=\"_blank\">IRAK4</a>) that plays a key role in innate immune responses against foreign pathogens.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524397\" data-linked=\"Curis up 8% premarket on encouraging CA-4948 in NHL\" data-tweet=\"$CRIS - Curis up 8% premarket on encouraging CA-4948 in NHL https://seekingalpha.com/news/3524397-curis-up-8-premarket-on-encouraging-caminus-4948-in-nhl?source=tweet\" data-url=\"https://seekingalpha.com/news/3524397-curis-up-8-premarket-on-encouraging-caminus-4948-in-nhl\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524410\" data-ts=\"1575640370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524410-onconova-up-24-premarket-on-rigosertib-access-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova up 24% premarket on rigosertib access program</a></h4><ul> <li>Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics, Inc.'>ONTX</a>) and Inceptua Medicines Access (a business unit of the Inceptua Group) will <a href=\"https://seekingalpha.com/pr/17720746-inceptua-medicines-access-and-onconova-therapeutics-announce-pre-approval-access\" target=\"_blank\">collaborate</a> to make available intravenous rigosertib via a Pre-approval Access Program in selected countries.</li>   <li>Rigosertib, in its intravenous formulation, is currently in Phase 3 development for the treatment of higher-risk myelodysplastic syndromes.</li>  <li>The rigosertib Pre-approval Access Program is expected to launch in H1 2020. Under the terms of this agreement, Inceptua will support Onconova by supplying intravenous rigosertib to countries like Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.</li><li>Shares are up <font color=\"green\">24%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3524410\" data-linked=\"Onconova up 24% premarket on rigosertib access program\" data-tweet=\"$ONTX - Onconova up 24% premarket on rigosertib access program https://seekingalpha.com/news/3524410-onconova-up-24-premarket-on-rigosertib-access-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3524410-onconova-up-24-premarket-on-rigosertib-access-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524407\" data-ts=\"1575639866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZM\" target=\"_blank\">ZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524407-zoom-targets-cut-on-size-of-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoom targets cut on size of earnings beat</a></h4><ul><li>RBC Capital analyst Alex Zukin maintains a Sector Perform rating on Zoom Video (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>) but cuts the target by $20 to $75 after yesterday's <a href=\"https://seekingalpha.com/news/3524168-zoom-video-communications-eps-beats-0_06-beats-on-revenue\" target=\"_blank\">earnings report</a>.</li><li>Zukin notes that the narrowing revenue beat and divergence of the billings and RPO growth rates could pressure shares in the near-term.</li><li>The analyst still thinks Zoom \"demonstrates one of the most capital-efficient sales motions in enterprise software\" and sees \"numerous\" growth drivers.</li><li>More action: Bernstein (Outperform) cuts ZM from $120 to $107.</li><li>Bernstein says estimates \"will have to be aggressively revised upward over the next 8 quarters,\" which will make the valuation \"look more palatable.\"</li><li>Zoom shares are <font color=\"red\">down 8.6%</font> pre-market to $63.65. The company has a Neutral average <a href=\"https://seekingalpha.com/symbol/ZM?s=zm\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524407\" data-linked=\"Zoom targets cut on size of earnings beat\" data-tweet=\"$ZM - Zoom targets cut on size of earnings beat https://seekingalpha.com/news/3524407-zoom-targets-cut-on-size-of-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3524407-zoom-targets-cut-on-size-of-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524406\" data-ts=\"1575639827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLUG\" target=\"_blank\">PLUG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524406-plug-power-prices-40m-share-offering-2_75\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plug Power prices 40M-share offering at $2.75</a></h4><ul><li>Plug Power (NASDAQ:<a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power Inc.'>PLUG</a>) <font color=\"red\">-5.2%</font> pre-market after pricing its recently announced public offering of 40M common shares at <a href=\"https://seekingalpha.com/pr/17720601-plug-power-inc-announces-pricing-of-public-offering-of-common-stock\" target=\"_blank\">$2.75/share</a>, for expected gross proceeds of $110M.</li><li>Plug also grants the underwriters a 30-day option to purchase up to an additional 6M shares.</li><li>The company plans to use the proceeds from the offering for working capital and other  general corporate purposes, including capital expenditures.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524406\" data-linked=\"Plug Power prices 40M-share offering at $2.75\" data-tweet=\"$PLUG - Plug Power prices 40M-share offering at $2.75 https://seekingalpha.com/news/3524406-plug-power-prices-40m-share-offering-2_75?source=tweet\" data-url=\"https://seekingalpha.com/news/3524406-plug-power-prices-40m-share-offering-2_75\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524405\" data-ts=\"1575639724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524405-stocks-and-yields-head-higher-after-strong-jobs-print\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks and yields head higher after strong jobs print</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3524399-november-payrolls-blowout-266k-jobs-added-ue-rate-to-3_5\" target=\"_blank\">November nonfarm payrolls were up</a> 266K vs. 186K expected, and October's gain was upwardly revised to 156K from 128K. The unemployment rate unexpectedly dipped to 3.5%.</li><li>Bond yields have knee-jerked upward, with the 10-year Treasury up to 1.85% vs. 1.78% prior to the number. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"red\">-0.5%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"green\">+1%</font></li><li>Up a hair prior to the print, S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) futures are now <font color=\"green\">higher by 0.5%</font>.</li><li>Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) has <font color=\"red\">dropped about $10</font> per ounce since the news, and the dollar (<a href='https://seekingalpha.com/symbol/UUP' title='Invesco DB USD Bullish ETF'>UUP</a>, <a href='https://seekingalpha.com/symbol/UDN' title='Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bearish Fund'>UDN</a>) has moved the opposite direction.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524405\" data-linked=\"Stocks and yields head higher after strong jobs print\" data-tweet=\"$TLT $TBT $SPY - Stocks and yields head higher after strong jobs print https://seekingalpha.com/news/3524405-stocks-and-yields-head-higher-after-strong-jobs-print?source=tweet\" data-url=\"https://seekingalpha.com/news/3524405-stocks-and-yields-head-higher-after-strong-jobs-print\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524395\" data-ts=\"1575639581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHVN\" target=\"_blank\">BHVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524395-biohaven-up-8-premarket-on-continuation-of-troriluzole-study-in-alzheimers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biohaven up 8% premarket on continuation of troriluzole study in Alzheimer&#39;s</a></h4><ul><li>Based on a futility analysis by the independent Data Safety Monitoring Board, the ongoing <a href=\"https://clinicaltrials.gov/ct2/show/NCT03605667?lead=biohaven&amp;phase=12&amp;draw=2&amp;rank=3\" target=\"_blank\">Phase 2/3 clinical trial</a> evaluating Biohaven Pharmaceuticals' (NYSE:<a href='https://seekingalpha.com/symbol/BHVN' title='Biohaven Pharmaceutical Holding Company Ltd.'>BHVN</a>) troriluzole in Alzheimer's disease patients will <a href=\"https://seekingalpha.com/pr/17720742-biohavens-troriluzole-successfully-advances-past-interim-futility-analysis-in-pivotal-phase-2\" target=\"_blank\">continue as planned</a>.</li><li>The primary endpoints are the change from baseline in two AD scales, ADAS-Cog 11 and CDR-Sum of boxes, at week 48 compared to placebo. The estimated completion date is December 2020.</li><li>On another note, the USPTO has <a href=\"https://seekingalpha.com/pr/17720538-biohaven-announces-issuance-of-composition-of-matter-patent-on-troriluzole-u-s-patent-and\" target=\"_blank\">issued</a> a new composition of matter patent covering troriluzole with an expiration date of February 26, 2036.</li><li>Shares are up <font color=\"green\">8%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524395\" data-linked=\"Biohaven up 8% premarket on continuation of troriluzole study in Alzheimer&#39;s\" data-tweet=\"$BHVN - Biohaven up 8% premarket on continuation of troriluzole study in Alzheimer&#39;s https://seekingalpha.com/news/3524395-biohaven-up-8-premarket-on-continuation-of-troriluzole-study-in-alzheimers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524395-biohaven-up-8-premarket-on-continuation-of-troriluzole-study-in-alzheimers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524394\" data-ts=\"1575638685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCO\" target=\"_blank\">GCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524394-genescoplus-15-after-earnings-smasher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesco +15% after earnings smasher</a></h4><ul> <li>Genesco (NYSE:<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a>) races higher in early trading after reporting comparable sales growth of 3.0% in <a href=\"https://seekingalpha.com/pr/17720694-genesco-inc-reports-fiscal-2020-third-quarter-results\" target=\"_blank\">Q3</a> to top the consensus mark of +1.7%.</li> <li>Genesco points to ongoing strength of the Journeys business and a much improved performance from Schuh in the U.K. as drivers of the comp sales growth.</li> <li>Looking ahead, Genesco sees FY20 comparable sales growth of 2% to 3% and EPS of $4.10 to $4.40 vs. $3.80 to $4.20 prior view and $4.05 consensus.</li> <li>Shares of Genesco are <font color=\"green\">up 15.15%</font> in premarket action to $42.50 vs. the 52-week trading range of $31.65 to $50.73.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524333-genesco-eps-beats-0_25-misses-on-revenue\" target=\"_blank\">Genesco EPS beats by $0.25, misses on revenue</a> (Dec. 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3524394\" data-linked=\"Genesco +15% after earnings smasher\" data-tweet=\"$GCO - Genesco +15% after earnings smasher https://seekingalpha.com/news/3524394-genescoplus-15-after-earnings-smasher?source=tweet\" data-url=\"https://seekingalpha.com/news/3524394-genescoplus-15-after-earnings-smasher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524390\" data-ts=\"1575637969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMED\" target=\"_blank\">AMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524390-bofaml-likes-hca-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML likes HCA in premarket analyst action</a></h4><ul><li>Amedisys (NASDAQ:<a href='https://seekingalpha.com/symbol/AMED' title='Amedisys, Inc.'>AMED</a>) initiated with Market Perform rating and $170 (3% upside) price target at BMO.</li><li>Athenex (NASDAQ:<a href='https://seekingalpha.com/symbol/ATNX' title='Athenex, Inc.'>ATNX</a>) initiated with Buy rating and $28 (70% upside) price target at SunTrust.</li><li>Gossamer Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/GOSS' title='Gossamer Bio, Inc.'>GOSS</a>) initiated with Overweight rating and $34 (38% upside) price target at Cantor Fitzgerald.</li><li>Magenta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGTA' title='Magenta Therapeutics, Inc.'>MGTA</a>) initiated with Buy rating and $20 (54% upside) price target at BTIG Research.</li><li>Odonate Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ODT' title='Odonate Therapeutics, Inc.'>ODT</a>) initiated with Sell rating and $26 (22% downside risk) price target at Goldman Sachs.</li><li>Puma Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>) initiated with Buy rating and $15 (102% upside) price target at H.C. Wainwright. Shares up <font color=\"green\">6%</font> premarket.</li><li>Sierra Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a>) initiated with Outperform rating and $1.20 (213% upside) price target at Oppenheimer. Shares up <font color=\"green\">30%</font> premarket.</li><li>Epizyme (NASDAQ:<a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme, Inc.'>EPZM</a>) upgraded to Overweight with a $22 (44% upside) price target at Morgan Stanley.</li><li>HCA Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/HCA' title='HCA Healthcare, Inc.'>HCA</a>) upgraded to Buy with a $160 (14% upside) price target at BofA Merrill Lynch.</li><li>Sage Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics, Inc.'>SAGE</a>) upgraded to Market Perform at SVB Leerink. Shares up <font color=\"green\">2%</font> premarket.</li><li>Anthem (NYSE:<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a>) downgraded to Neutral with a $330 (15% upside) price target at BofAML.</li><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) downgraded to Hold with an $80 (1% upside) price target at Jefferies. Shares down <font color=\"red\">2% </font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524390\" data-linked=\"BofAML likes HCA in premarket analyst action\" data-tweet=\"$AMED $ATNX $GOSS - BofAML likes HCA in premarket analyst action https://seekingalpha.com/news/3524390-bofaml-likes-hca-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3524390-bofaml-likes-hca-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524383\" data-ts=\"1575637734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISEE\" target=\"_blank\">ISEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524383-iveric-bio-down-3-premarket-on-pricing-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IVERIC bio down 3% premarket on pricing common stock offering</a></h4><ul> <li>IVERIC bio (NASDAQ:<a href='https://seekingalpha.com/symbol/ISEE' title='IVERIC bio, Inc.'>ISEE</a>) has <a href=\"https://seekingalpha.com/pr/17720761-iveric-bio-inc-announces-pricing-of-public-offering-of-common-stock\" target=\"_blank\">priced</a> its public offering of 6.25M common shares at $4.00 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 3.75M common shares at $3.999 per pre-funded warrant, for expected gross proceeds of ~$40M.</li><li>Underwriters' over-allotment is an additional 1.5M shares.</li><li>Closing date is December 10.</li><li>Shares are down <font color=\"red\">3%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524163-iveric-bio-launches-equity-offering-shares-down-13-after-hours\" target=\"_blank\">Iveric bio launches equity offering; shares down 13% after hours</a> (Dec. 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3524383\" data-linked=\"IVERIC bio down 3% premarket on pricing common stock offering\" data-tweet=\"$ISEE - IVERIC bio down 3% premarket on pricing common stock offering https://seekingalpha.com/news/3524383-iveric-bio-down-3-premarket-on-pricing-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3524383-iveric-bio-down-3-premarket-on-pricing-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524376\" data-ts=\"1575637050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTEC\" target=\"_blank\">TTEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524376-ttec-prices-secondary-offering-sharesminus-2_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TTEC prices secondary offering; shares -2.4%</a></h4><ul><li>TTEC (NASDAQ:<a href='https://seekingalpha.com/symbol/TTEC' title='TTEC Holdings, Inc.'>TTEC</a>) <a href=\"https://seekingalpha.com/pr/17720755-ttec-holdings-inc-announces-pricing-of-secondary-offering\" target=\"_blank\">prices</a> the <a href=\"https://seekingalpha.com/news/3523176-ttecminus-2_7-ceo-offers-3m-shares\" target=\"_blank\">secondary offering</a> of 3M shares by CEO Kenneth Tuchman.</li><li>The offering is priced at $36.50/share and is expected to close on or around December 10.</li><li>Underwriters have a 30-day option to purchase an additional 450K shares.</li><li>TTEC won't receive any proceeds from the sale.</li><li>TTEC shares are <font color=\"red\">down 2.4%</font> pre-market to $37.18.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524376\" data-linked=\"TTEC prices secondary offering; shares -2.4%\" data-tweet=\"$TTEC - TTEC prices secondary offering; shares -2.4% https://seekingalpha.com/news/3524376-ttec-prices-secondary-offering-sharesminus-2_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3524376-ttec-prices-secondary-offering-sharesminus-2_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524369\" data-ts=\"1575636642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PD\" target=\"_blank\">PD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524369-pagerduty-16_6-after-wider-loss-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PagerDuty 16.6% after wider loss outlook</a></h4><ul><li>PagerDuty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) is <font color=\"red\">down 16.6%</font> after yesterday's <a href=\"https://seekingalpha.com/news/3524175-pagerduty-eps-misses-0_01-beats-on-revenue\" target=\"_blank\">Q3 report</a> included a wider than expected loss.</li><li>The mixed Q4 outlook sees upside revenue of $44.5-45.5M and downside loss per share of $0.07-0.06.</li><li>New hire: David Justice will join the company as the new CRO. Justice most recently served as the EVP of Enterprise Sales at Salesforce.</li><li>Earnings <a href=\"https://seekingalpha.com/pr/17720354-pagerduty-announces-third-quarter-fiscal-year-2020-financial-results\" target=\"_blank\">press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524369\" data-linked=\"PagerDuty 16.6% after wider loss outlook\" data-tweet=\"$PD - PagerDuty 16.6% after wider loss outlook https://seekingalpha.com/news/3524369-pagerduty-16_6-after-wider-loss-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3524369-pagerduty-16_6-after-wider-loss-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524359\" data-ts=\"1575635314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524359-cienaminus-2_8-ubs-becomes-bearish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena -2.8% as UBS becomes bearish</a></h4><ul><li>Ciena (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) is downgraded from Neutral to Sell at UBS. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/CIEN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a> with UBS as the first bearish call.</li><li>The firm cuts the target from $43 to $31, citing operational expectations that UBS believes are too high.</li><li>CIEN shares are <font color=\"red\">down 2.8%</font> pre-market to $35.27.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524359\" data-linked=\"Ciena -2.8% as UBS becomes bearish\" data-tweet=\"$CIEN - Ciena -2.8% as UBS becomes bearish https://seekingalpha.com/news/3524359-cienaminus-2_8-ubs-becomes-bearish?source=tweet\" data-url=\"https://seekingalpha.com/news/3524359-cienaminus-2_8-ubs-becomes-bearish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524351\" data-ts=\"1575634805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524351-trade-deskplus-4-needham-leaves-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trade Desk +4% as Needham leaves sidelines</a></h4><ul><li>Needham upgrades Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) from Hold to Buy with a $325 target, a 35% increase.</li><li>The firm cites the supportive near-term ad spend outlook and growth opportunities as tech giants Amazon, Facebook, and Google face regulatory scrutiny.</li><li>TTD shares are <font color=\"green\">up 4.4%</font> pre-market to $250.97.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524351\" data-linked=\"Trade Desk +4% as Needham leaves sidelines\" data-tweet=\"$TTD - Trade Desk +4% as Needham leaves sidelines https://seekingalpha.com/news/3524351-trade-deskplus-4-needham-leaves-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3524351-trade-deskplus-4-needham-leaves-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524347\" data-ts=\"1575634580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524347-netflix-ups-content-spending-in-india\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix ups content spending in India</a></h4><ul> <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) plans to invest <a href=\"https://techcrunch.com/2019/12/06/netflix-earmarks-420m-to-fight-disney-in-india/\" target=\"_blank\">~$420M</a> in India in an effort to develop and license new content for the region.</li> <li>An industry source tells TechCrunch that no streaming service in India is spending nearly as much as content.</li> <li>Despite facing competition in India from more than three dozen other streaming services, the company posted revenue of $65M and a profit of about $720K in the region for the last fiscal year.</li> <li>Shares of Netflix are <font color=\"green\">up 0.29%</font> in premarket action to $303.74.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3524347\" data-linked=\"Netflix ups content spending in India\" data-tweet=\"$NFLX - Netflix ups content spending in India https://seekingalpha.com/news/3524347-netflix-ups-content-spending-in-india?source=tweet\" data-url=\"https://seekingalpha.com/news/3524347-netflix-ups-content-spending-in-india\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524333\" data-ts=\"1575633129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCO\" target=\"_blank\">GCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524333-genesco-eps-beats-0_25-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesco EPS beats by $0.25, misses on revenue</a></h4><ul><li>Genesco (NYSE:<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a>): Q2 Non-GAAP EPS of $1.33 <font color=\"green\">beats by $0.25</font>; GAAP EPS of $1.31 <font color=\"green\">beats by $0.27</font>.</li><li>Revenue of $537.26M (-0.5% Y/Y) <font color=\"red\">misses by $3.38M</font>.</li><li>Shares <font color=\"green\">+8.37%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17720694-genesco-inc-reports-fiscal-2020-third-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3524333\" data-linked=\"Genesco EPS beats by $0.25, misses on revenue\" data-tweet=\"$GCO - Genesco EPS beats by $0.25, misses on revenue https://seekingalpha.com/news/3524333-genesco-eps-beats-0_25-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3524333-genesco-eps-beats-0_25-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524329\" data-ts=\"1575632659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAVA\" target=\"_blank\">SAVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524329-cassava-up-41-premarket-on-encouraging-data-on-ptiminus-125-in-alzheimers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cassava up 41% premarket on encouraging data on PTI-125 in Alzheimer&#39;s</a></h4><ul><li>Thinly traded nano cap Cassava Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVA' title='Cassava Sciences, Inc.'>SAVA</a>) is up <font color=\"green\">41% </font>premarket on increased volume in reaction to <a href=\"https://seekingalpha.com/pr/17720610-cassava-sciences-announces-additional-positive-phase-2a-clinical-data-in-alzheimer-s-disease\" target=\"_blank\">new data</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT04079803?term=cassava+sciences&amp;draw=2&amp;rank=1\" target=\"_blank\">Phase 2a clinical trial</a> evaluating lead drug PTI-125 in patients with mild-to-moderate Alzheimer's disease &#40;AD&#41;. The results were presented at the Clinical Trials on Alzheimer's Disease Conference in San Diego.</li><li>Consistent improvements in AD biomarkers in plasma and lymphocytes were noted including evidence that each patient showed biomarker responses to PTI-125.</li><li>Significant reductions in both nitrated and phosphorylated forms of tau protein were observed.</li><li>Early clinical validation of the drug target, altered filamin A, as a facilitator protein between amyloid beta and both neuroinflammation and tau pathology.</li><li>Topline data are expected in 2020.</li><li>Small molecule <a href=\"https://www.cassavasciences.com/pti-125\" target=\"_blank\">PTI-125</a> targets an altered form of filamin A, a scaffolding protein found throughout the body. A highly toxic form of the protein is present in the brains of AD sufferers which disrupts the normal function of neurons, leading to neurodegeneration and brain inflammation. PTI-125 is designed to restore the normal shape of filamin A in the brain, improving the function of multiple brain receptors and dampening neuroinflammation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524329\" data-linked=\"Cassava up 41% premarket on encouraging data on PTI-125 in Alzheimer&#39;s\" data-tweet=\"$SAVA - Cassava up 41% premarket on encouraging data on PTI-125 in Alzheimer&#39;s https://seekingalpha.com/news/3524329-cassava-up-41-premarket-on-encouraging-data-on-ptiminus-125-in-alzheimers?source=tweet\" data-url=\"https://seekingalpha.com/news/3524329-cassava-up-41-premarket-on-encouraging-data-on-ptiminus-125-in-alzheimers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524318\" data-ts=\"1575630627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIG\" target=\"_blank\">BIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524318-big-lots-beats-q3-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big Lots beats Q3 estimates</a></h4><ul><li>Big Lots (NYSE:<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a>) reports comparable-store sales decreased 0.1% in <a href=\"https://seekingalpha.com/pr/17720677-big-lots-reports-q3-comps-and-adjusted-eps-in-line-guidance\" sasource=\"qp_sum_news_7\" target=\"_blank\">Q3</a>, comparable to the guidance of ~flat.</li><li>Gross margin rate down 20 bps to 39.7%.</li><li>SG&amp;A expense rate improved 60 bps to 37.4%.</li><li>Operating income margin rate was 14.6%.</li><li>Inventory increased 4% Y/Y to $1.12B.</li><li><b>Q4 Guidanc</b>e: Comparable-store sales: up slightly; Diluted EPS: $2.40 to $2.55.</li><li><b>FY2019 Guidance</b>: Diluted EPS: $6.20 to $6.35; Adjusted EPS: $3.70 to $3.85.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3524315-big-lots-eps-beats-0_02-beats-on-revenue\" target=\"_blank\">Big Lots EPS beats by $0.02, beats on revenue</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3524318\" data-linked=\"Big Lots beats Q3 estimates\" data-tweet=\"$BIG - Big Lots beats Q3 estimates https://seekingalpha.com/news/3524318-big-lots-beats-q3-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3524318-big-lots-beats-q3-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3524292\" data-ts=\"1575627768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3524292-futures-higher-november-jobs-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures higher before November jobs report</a></h4><ul><li>Settling slightly in the green on Thursday, U.S. stock index futures <font color=\"green\">advanced by 0.4%</font> overnight, ahead of the eagerly-anticipated <a href=\"https://seekingalpha.com/news/3524289-gm-effect-seen-boosting-nonfarm-payrolls\" target=\"_blank\">November jobs report</a>.</li><li>Market focus is additionally attuned to global trade developments, following an upbeat tone from President Trump.</li><li>Adding to the positive sentiment, China's finance ministry <a href=\"https://www.cnbc.com/2019/12/06/china-says-it-will-waive-import-tariffs-for-some-us-soybeans-and-pork.html\" target=\"_blank\">said</a> on Friday it will waive import tariffs for some soybeans and pork shipments from the U.S. as the two sides aim to conclude a Phase One trade deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3524292\" data-linked=\"Futures higher before November jobs report\" data-tweet=\"Futures higher before November jobs report https://seekingalpha.com/news/3524292-futures-higher-november-jobs-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3524292-futures-higher-november-jobs-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":58,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}